SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-006719
Filing Date
2021-06-17
Accepted
2021-06-17 18:51:27
Documents
1
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-53147.html 4  
1 PRIMARY DOCUMENT marketforms-53147.xml 4 4663
  Complete submission text file 0001214659-21-006719.txt   6077
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 MAIN STREET, SUITE 1900 FORT WORTH TX 76102
Business Address
Cochran John (Reporting) CIK: 0001406773 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 211026407